Found "Health Policies": 1,061 results
Sort by
Relevance

Gates Foundation calls for more principled cost-effectiveness in health

This is a post by Amanda Glassman reproduced with permission from the Center for Global DevelopmentCost-effectiveness studies compare the costs and benefits of different interventions with the aim of improving decisions on the allocation of scarce resources for health.  Or, put simply, they allow po

Supreme Court Lets Health Law Largely Stand, in Victory for Obama

WASHINGTON — The Supreme Court on Thursday upheld President Obama’s health care overhaul law, saying its requirement that most Americans obtain insurance or pay a penalty was authorized by Congress’s power to levy taxes. The vote was 5 to 4, with Chief Justice John G. Roberts Jr. joining the court’s

Navigating Healthcare Innovations: Key Takeaways from the HIPER Symposium 2024 

In a constantly evolving world of healthcare, staying updated and informed about new developments and innovations is essential. The Health Intervention and Technology Assessment Program (HITAP), a Health Technology Assessment (HTA) organisation in the Ministry of Public Health, Thailand, had the opp

Too Much Medical Care?

A few years ago, my daughter sprained her ankle at dance camp. What happened next offers a glimpse into some of the problems in our nation’s health care system.For years, we’ve been hearing that the United States spends more on health care than any other country, even as it lags far behind other cou

5th Annual HTAsiaLink Conference

The 5th annual HTAsiaLink Conference officially concludes after a four-day intensive gathering of HTA practitioners and experts in Singapore. The conference was jointly organized by the Ministry of Health, Singapore, the Health Services Research Department of the Eastern Health Alliance and the Heal

Review of Literature and Information to Support and Pilot testing the Process for Integrating Thai Innovation into Thailand’s Universal Health Coverage System: A Case Study of Advance Wound Dressing from the Thai Innovation List

The development of health and medical innovation is a key national strategy for Thailand under the 13th National Economic and Social Development Plan, which aims to position the country as a high-value medical and wellness hub while reducing dependence on imported medical technologies. The Thai Innovation List was established to promote the commerc

Capacity Building for Health Technology Assessment (HTA) in ASEAN (2021–2025): Report to ASEAN Health Cluster 3 Secretariat

This report provides an overview of regional efforts to strengthen HTA capacity across Southeast Asia under the Association of Southeast Asian Nations (ASEAN) Health Cluster 3 (AHC 3) Work Programme. Led by Health Intervention and Technology Assessment Program Foundation (HITAP), in collaboration

Technical Report: Exploring Digital Health and Telemedicine Practices: A Study Visit to Singapore

Thailand is in the process of adopting technologies appropriate for its context to provide telemedicine on a national scale. However, there are some gaps that make achieving universal telemedicine in Thailand challenging on certain areas. Technological factors and the lack of a uniform information s

The role of health technology assessment evidence in decision making: the case of Human Papillomavirus vaccination

Introduction: Cervical cancer is a major cause of deaths in female in low- and middle-income countries. The disease is preventable by introducing screening tests such as Pap smears, visual inspection with acetic acid (VIA) and HPV DNA testing. Recently, the first vaccine against human papillomavirus (HPV) was introduced to the health care market t

Assessing the implications of Thailand’s government use licenses, issued in 2006-2008

This study aims to assess the impact of the compulsory licensing (CL ) policy issued by Thailand’s Ministry of Public Health during December 2006 to January 2008 on antiretroviral drugs - efavirenz and lopinavir/ritonavir combination, an oral antiplatelet agent - clopidogrel, and four anti-cancer drugs - imatinib, erlotinib, letrozole, and doceta
10 / Page